Chinese Aspirin "Dumping" Is Under Trade Commission Investigation
This article was originally published in The Tan Sheet
Executive Summary
The International Trade Commission is instituting an investigation into evidence of possible Chinese aspirin "dumping" onto the U.S. market, the commission announced in the Federal Register June 7. The investigation follows a May 28 petition from bulk aspirin manufacturer Rhodia requesting the "imposition of antidumping duties on imports of bulk aspirin from the People's Republic of China."
You may also be interested in...
Chinese aspirin
Antidumping margin of 144% applicable to all but two bulk aspirin exporters in the People's Republic of China, the International Trade Administration says in a final determination published in the Federal Register May 25. ITA assigns weighted-average dumping margins of 42.8% to Shandong Xinhau Pharmaceutical Factory and 4.7% to Jilin Pharmaceutical. The case now goes to the International Trade Commission, which will issue an antidumping order if it determines Chinese bulk aspirin imports are materially injurious, or threaten material injury, to U.S. industry. The investigation was requested by Cranbury, N.J.-based bulk aspirin maker Rhodia (1"The Tan Sheet" June 14, 1999, p. 9)
Chinese aspirin
Antidumping margin of 144% applicable to all but two bulk aspirin exporters in the People's Republic of China, the International Trade Administration says in a final determination published in the Federal Register May 25. ITA assigns weighted-average dumping margins of 42.8% to Shandong Xinhau Pharmaceutical Factory and 4.7% to Jilin Pharmaceutical. The case now goes to the International Trade Commission, which will issue an antidumping order if it determines Chinese bulk aspirin imports are materially injurious, or threaten material injury, to U.S. industry. The investigation was requested by Cranbury, N.J.-based bulk aspirin maker Rhodia (1"The Tan Sheet" June 14, 1999, p. 9)
Chinese aspirin
Antidumping margin of 144% applicable to all but two bulk aspirin exporters in the People's Republic of China, the International Trade Administration says in a final determination published in the Federal Register May 25. ITA assigns weighted-average dumping margins of 42.8% to Shandong Xinhau Pharmaceutical Factory and 4.7% to Jilin Pharmaceutical. The case now goes to the International Trade Commission, which will issue an antidumping order if it determines Chinese bulk aspirin imports are materially injurious, or threaten material injury, to U.S. industry. The investigation was requested by Cranbury, N.J.-based bulk aspirin maker Rhodia (1"The Tan Sheet" June 14, 1999, p. 9)